Skip to main content
Top
Published in: Archives of Virology 7/2013

01-07-2013 | Original Article

Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients

Authors: Cristina Costa, Antonio Curtoni, Francesca Sidoti, Cinzia Balloco, Salvatore Simeone, Samantha Mantovani, Elsa Piasentin Alessio, Daniela Libertucci, Luisa Delsedime, Paolo Solidoro, Sergio Baldi, Rossana Cavallo

Published in: Archives of Virology | Issue 7/2013

Login to get access

Abstract

The role of human cytomegalovirus (HCMV) in lung transplantation (LT) and drawbacks related to viral quantification in bronchoalveolar lavage (BAL) underline the potential usefulness of investigating other specimens. Thirty-three LT recipients were prospectively studied by HCMV quantitative real time PCR on matched transbronchial biopsy (TBB), BAL, and whole blood specimens. Overall, 27/33 patients turned out HCMV-positive in at least one specimen: 7.1 %, 37.1 %, and 13.5 % of TBB, BAL, and blood samples, respectively. No significant association between HCMV on all types of specimens and acute rejection, lymphocytic bronchiolitis, bronchiolitis obliterans and bronchiolitis obliterans syndrome was found. HCMV pneumonia was associated to HCMV detection on TBB (p = 0.003) and whole blood (p = 0.008), not on BAL (p = 0.47). The highest mean viral load was detected in TBB from cases with HCMV pneumonia in comparison to all other cases, suggesting the potential use of HCMV investigation in TBB for evaluating posttransplant complications.
Literature
1.
go back to reference Costa C, Curtoni A, Bergallo M et al (2011) Quantitative detection of HHV-6 and HHV-7 in transbronchial biopsies from lung transplant recipients. New Microbiol 34:275–280PubMed Costa C, Curtoni A, Bergallo M et al (2011) Quantitative detection of HHV-6 and HHV-7 in transbronchial biopsies from lung transplant recipients. New Microbiol 34:275–280PubMed
2.
go back to reference Zedtwitz-Liebenstein K, Jaksch P, Bauer C et al (2004) Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation 77:1897–1899PubMedCrossRef Zedtwitz-Liebenstein K, Jaksch P, Bauer C et al (2004) Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients. Transplantation 77:1897–1899PubMedCrossRef
3.
go back to reference Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC (2004) Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 190:1076–1083PubMedCrossRef Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC (2004) Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 190:1076–1083PubMedCrossRef
4.
go back to reference Solidoro P, Delsedime L, Bergallo M et al (2009) Combined prophylaxis decreases incidence of CMV-associated pneumonia after lung transplantation. Transplant Proc 41:1347–1348PubMedCrossRef Solidoro P, Delsedime L, Bergallo M et al (2009) Combined prophylaxis decreases incidence of CMV-associated pneumonia after lung transplantation. Transplant Proc 41:1347–1348PubMedCrossRef
5.
go back to reference Costa C, Libertucci D, Solidoro et al (2007) Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients. Panminerva Med 49:1–6 Costa C, Libertucci D, Solidoro et al (2007) Rapid shell vial culture for the detection of respiratory viruses from bronchoalveolar lavage in immunocompromised patients. Panminerva Med 49:1–6
6.
go back to reference Gerna G, Lilleri D, Furione M, Baldanti F (2011) Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol 34:229–254PubMed Gerna G, Lilleri D, Furione M, Baldanti F (2011) Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol 34:229–254PubMed
7.
go back to reference Estenne M, Maurer JR, Boehler A et al (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310PubMedCrossRef Estenne M, Maurer JR, Boehler A et al (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21:297–310PubMedCrossRef
8.
go back to reference Costa C, Delsedime L, Solidoro P et al (2010) Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. Transplant Proc 42:1270–1274PubMedCrossRef Costa C, Delsedime L, Solidoro P et al (2010) Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation. Transplant Proc 42:1270–1274PubMedCrossRef
9.
go back to reference Costa C, Bergallo M, Astegiano S et al (2011) Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients. Arch Virol 156:1439–1443PubMedCrossRef Costa C, Bergallo M, Astegiano S et al (2011) Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients. Arch Virol 156:1439–1443PubMedCrossRef
10.
go back to reference Costa C, Elia M, Astegiano S et al (2008) Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation 86:1389–1394PubMedCrossRef Costa C, Elia M, Astegiano S et al (2008) Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation 86:1389–1394PubMedCrossRef
11.
go back to reference Stewart S, Fishbein MC, Snell GI et al (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26:1229–1242PubMedCrossRef Stewart S, Fishbein MC, Snell GI et al (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26:1229–1242PubMedCrossRef
12.
go back to reference Puchhammer-Stöckl E (2008) Herpesviruses and the transplanted lung: looking at the air side. J Clin Virol 43:415–418PubMedCrossRef Puchhammer-Stöckl E (2008) Herpesviruses and the transplanted lung: looking at the air side. J Clin Virol 43:415–418PubMedCrossRef
13.
go back to reference Bauer CC, Jaksch P, Aberle SW et al (2007) Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45:324–328PubMedCrossRef Bauer CC, Jaksch P, Aberle SW et al (2007) Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol 45:324–328PubMedCrossRef
14.
go back to reference Verleden GM, Dupont LJ, Van Raemdonck DE (2005) Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 25:221–224PubMedCrossRef Verleden GM, Dupont LJ, Van Raemdonck DE (2005) Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 25:221–224PubMedCrossRef
15.
go back to reference Chemaly RF, Yen-Lieberman B, Castilla EA et al (2004) Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 42:2168–2172PubMedCrossRef Chemaly RF, Yen-Lieberman B, Castilla EA et al (2004) Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 42:2168–2172PubMedCrossRef
16.
go back to reference Morbini P, Arbustini E (2001) In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung. Virchows Arch 438:558–566PubMedCrossRef Morbini P, Arbustini E (2001) In situ characterization of human cytomegalovirus infection of bronchiolar cells in human transplanted lung. Virchows Arch 438:558–566PubMedCrossRef
17.
go back to reference Jacobs F, Knoop C, Brancart F et al (2003) Human herpesvirus-6 infection after lung and heart–lung transplantation: a prospective longitudinal study. Transplantation 75:1996–2001PubMedCrossRef Jacobs F, Knoop C, Brancart F et al (2003) Human herpesvirus-6 infection after lung and heart–lung transplantation: a prospective longitudinal study. Transplantation 75:1996–2001PubMedCrossRef
18.
go back to reference Gerna G, Lilleri D, Rognoni V et al (2009) Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Am J Transplant 9:1142–1150 Gerna G, Lilleri D, Rognoni V et al (2009) Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Am J Transplant 9:1142–1150
Metadata
Title
Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients
Authors
Cristina Costa
Antonio Curtoni
Francesca Sidoti
Cinzia Balloco
Salvatore Simeone
Samantha Mantovani
Elsa Piasentin Alessio
Daniela Libertucci
Luisa Delsedime
Paolo Solidoro
Sergio Baldi
Rossana Cavallo
Publication date
01-07-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1607-9

Other articles of this Issue 7/2013

Archives of Virology 7/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.